Literature DB >> 18470714

Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.

M Oberhoffer1, S Russwurm, D Bredle, K Chatzinicolaou, K Reinhart.   

Abstract

OBJECTIVES: To determine the correlations and predictive strength of surrogate markers (body temperature, leukocyte count, C-reactive protein (CRP) and procalcitonin (PCT)) with elevated levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in septic patients on randomly chosen days.
DESIGN: Prospective consecutive case series.
SETTING: Surgical intensive care unit (ICU) of a university hospital. PATIENTS: Two hundred forty-three patients experiencing ICU stays of longer than 48 h categorized for sepsis according to ACCP/SCCM Consensus Conference criteria.
MEASUREMENTS AND MAIN RESULTS: CRP and PCT were both significantly correlated with TNF-alpha and IL-6. Based on the area under the curve (AUC) of the receiver operating characteristic (ROC) curves, predictive capability was highest for PCT (0.846 for TNF-alpha>40 pg/ml and 0.837 for IL-6>500 pg/ml), moderate with CRP (0.744 and 0.748, respectively), and lowest for leukocyte count (0.562 and 0.534, respectively) and body temperature (0.570 and 0.623, respectively). Sensitivity, specificity, positive and negative predictive values and test effectiveness all followed this same pattern of being highest for PCT followed by CRP, with leukocyte count and body temperature being lowest.
CONCLUSION: PCT may be an early and better marker of elevated cytokines than the more classic criteria of inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470714     DOI: 10.1007/BF02900732

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  20 in total

1.  Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

Authors:  M Oberhoffer; W Karzai; A Meier-Hellmann; D Bögel; J Fassbinder; K Reinhart
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

2.  Procalcitonin as a marker for the early diagnosis of neonatal infection.

Authors:  D Gendrel; M Assicot; J Raymond; F Moulin; C Francoual; J Badoual; C Bohuon
Journal:  J Pediatr       Date:  1996-04       Impact factor: 4.406

Review 3.  The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.

Authors:  T Darville; B Giroir; R Jacobs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Ectopic production of high molecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors.

Authors:  X Y Bertagna; W E Nicholson; O S Pettengill; G D Sorenson; C D Mount; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

6.  Predictors of bacteremia and gram-negative bacteremia in patients with sepsis. The Veterans Affairs Systemic Sepsis Cooperative Study Group.

Authors:  P Peduzzi; C Shatney; J Sheagren; C Sprung
Journal:  Arch Intern Med       Date:  1992-03

7.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Authors:  M R Pinsky; J L Vincent; J Deviere; M Alegre; R J Kahn; E Dupont
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

8.  PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.

Authors:  F Raue; E Blind; A Grauer
Journal:  Henry Ford Hosp Med J       Date:  1992

9.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

Review 10.  An overview of mortality risk prediction in sepsis.

Authors:  S L Barriere; S F Lowry
Journal:  Crit Care Med       Date:  1995-02       Impact factor: 7.598

View more
  8 in total

Review 1.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

2.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

Review 3.  Mass spectrometry for the discovery of biomarkers of sepsis.

Authors:  Katelyn R Ludwig; Amanda B Hummon
Journal:  Mol Biosyst       Date:  2017-03-28

Review 4.  [Use of biomarkers in sepsis. Update and perspectives].

Authors:  B H Siegler; S Weiterer; C Lichtenstern; D Stumpp; T Brenner; S Hofer; M A Weigand; F Uhle
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

5.  Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection.

Authors:  Michael Siassi; Jutta Riese; Rudi Steffensen; Michael Meisner; Steffen Thiel; Werner Hohenberger; Joachim Schmidt
Journal:  Crit Care       Date:  2005-07-19       Impact factor: 9.097

6.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

Review 7.  Rapid diagnosis of sepsis.

Authors:  Frank Bloos; Konrad Reinhart
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

Review 8.  Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit.

Authors:  John Alfred Carr
Journal:  J Intensive Care       Date:  2015-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.